<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03076866</url>
  </required_header>
  <id_info>
    <org_study_id>260</org_study_id>
    <nct_id>NCT03076866</nct_id>
  </id_info>
  <brief_title>Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism</brief_title>
  <acronym>PPCRNice</acronym>
  <official_title>Suivi Prospectif Des Patients Presentant un Rhumatisme Inflammatoire Chronique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a prospective follow-up. The aim is to study the maintenance of therapeutic at 10 years
      and 20 years of inflammatory rheumatism (rheumatoid arthritis and spondyloarthritis)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects were followed up on a yearly basis collection with clinical data (weight, sex,
      age, comorbidities, treatment), biological (VS, CRP, ACPA, lipid balance, cross laps),
      radiology (hand and foot radiographs and ultrasonography ), BMO Measure
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2001</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>therapeutic maintenance at 20 years of follow-up</measure>
    <time_frame>20 years</time_frame>
    <description>All subjects benefit from an annual follow-up including a collection of clinical data (age, sex, weight, comorbidities, swelling and painful joints), biological (CRP, ACPA, cross laps, lipids), radiological, BMO measures (Hologic), and treatments (biological and synthetic DMARDS). Each rheumatologic modification or stop of treatment is transcribed. Therapeutic maintenance definition: modification in rheumatologic treatment (number of DMARDS at 20 years)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evolution of lipidics parameters at 20 years of follow-up</measure>
    <time_frame>20 years</time_frame>
    <description>lipidics parameters ( total, HDL, LDL cholesterol and tryglicerides) are collected each years and modifications/evolution of these parameters will be studied</description>
  </secondary_outcome>
  <other_outcome>
    <measure>evolution of BMD at 20 years of follow-up</measure>
    <time_frame>20 years</time_frame>
    <description>each 2 years during visit of follow up, BMD parameters (Hologic QDR 4500A measurements performed in pasteur 2 hospital: tscore, Zscore and BMD in in g/cm2) are collected. Osteopenia was defined by a T-score between -1 and -2.5 SD and osteoporosis by a T-score below -2.5 SD, in accordance with the World Health Organization guidelines. evolution of BMD will be studied in relation with rheumatologics treatments</description>
  </other_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Inflammatory Disease</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Spondyloarthritis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observational follow-up:clinical, radiological et biological</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with a inflammatory disease (rheumatoid arthritis and spondyloarthritis)
        follow-up in the rheumatologic department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  More than 18 years

          -  Rheumatoid arthritis meeting ACR criteria Spondyloarthritis meeting ASAS criteria

        Exclusion Criteria:

          -  Patient under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>christian roux, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nice</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>christian H roux, PhD</last_name>
    <phone>492035512</phone>
    <email>roux.c2@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>rheumatology department CHU nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>christian H ROUX, PhD</last_name>
      <phone>492035512</phone>
      <email>roux.c2@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2017</study_first_submitted>
  <study_first_submitted_qc>March 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2017</study_first_posted>
  <last_update_submitted>March 13, 2017</last_update_submitted>
  <last_update_submitted_qc>March 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nice</investigator_affiliation>
    <investigator_full_name>Service de Rhumatologie</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

